Yvonne Brandberg

Karolinska Institutet

Papers

1

Total Citations

14

H-Index

1

About

Yvonne Brandberg is a leading researcher in oncology and health-related quality of life, with a particular focus on the long-term consequences of cancer treatment. Her work bridges clinical outcomes and patient-reported experiences, especially in gynecologic and breast cancers. A major contribution is the RASHEC trial, which provided critical data on lymphedema and serious adverse events one year after comprehensive staging for endometrial cancer—a study that has informed postoperative care and patient counseling. With over 14 citations for this landmark paper alone, Brandberg’s research has shaped understanding of survivorship issues, emphasizing the need for systematic monitoring of treatment side effects. She is also known for integrating patient perspectives into clinical trial design, ensuring that quality of life metrics are central to evaluating therapeutic success. Her work has been instrumental in advancing personalized care pathways, making her a respected voice in oncologic outcomes research. For students and researchers, Brandberg’s career exemplifies how rigorous clinical investigation can directly improve patient well-being.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial
14 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Karolinska Institutet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago